Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: Comparison with major depressive disorder

NMR in Biomedicine

Volumn 23, Issue 6, 2010, Pages 643-650

  Murrough, James W ^a   Mao, Xiangling ^b   Collins, Katherine A ^a   Kelly, Chris ^a   Andrade, Gizely ^a   Nestadt, Paul ^a,c   Levine, Susan M ^d   Mathew, Sanjay J ^a   Shungu, Dikoma C ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NONE

Author keywords

Cerebrospinal fluid; Chronic fatigue syndrome; Glutamate; Lactate; Magnetic resonance spectroscopy; Major depressive disorder; aminobutyric acid

Indexed keywords

AMINO ACIDS; BODY FLUIDS; BRAIN; FLUIDS; MAGNETIC MATERIALS; MAGNETIC RESONANCE; ORGANIC ACIDS; PARTICLE DETECTORS;

AMINOBUTYRIC ACIDS; BRAIN METABOLITES; CEREBRO SPINAL FLUIDS; CHRONIC FATIGUE SYNDROME; CHRONIC FATIGUE SYNDROMES; EXPLORATORY ANALYSIS; HEALTHY CONTROLS; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; NEUROPSYCHIATRIC DISORDER; SAMPLE SIZES; SENSITIVITY AND SPECIFICITY;

MAGNETIC RESONANCE SPECTROSCOPY;

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID;

ADULT; AGED; ARTICLE; BRAIN VENTRICLE; CEREBROSPINAL FLUID; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; DEVICES; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; CEREBRAL VENTRICLES; DEPRESSIVE DISORDER, MAJOR; FATIGUE SYNDROME, CHRONIC; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED;

EID: 77955106514     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1512     Document Type: Article

References (28)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann. Intern. Med. 1994; 121: 953-959.
2. Afari N, Buchwald D. Chronic fatigue syndrome: A review. Am. J. Psychiatry 2003; 160: 221-236.
3. Mathew SJ, Mao X, Keegan KA, Levine SM, Smith EL, Heier LA, Otcheretko V, Coplan JD, Shungu DC. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: An in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 2009; 22: 251-258.
4. Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder. Biol. Psychiatry 2009; 65: 792-800.
5. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004; 61: 705-713.
6. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1999; 56: 1043-1047.
7. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 2007; 64: 193-200.
8. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, M Matthews P, J Cowen P. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int. J. Neuropsychopharmacol. 2008; 11: 255-260.
9. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A, Matthews PM, Cowen PJ. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry. 2007; 61: 806-812.
10. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis Disorders (SCID). New York State Psychiatric Institute, Biometrics Research: New York, NY, 1995.
11. Smets EM, Garssen B, Bonke B, De Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995; 39: 315-325.
12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960; 23: 56-62.
13. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). Harcourt Assessment: San Antonio, 1999.
14. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology. 1993; 188: 277-282. (Pubitemid 23183139)
15. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 1989; 46: 1121-1123.
16. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 2005; 39: 584-589.
17. Robinson M, Gray SR, Watson MS, Kennedy G, Hill A, Belch JJ, Nimmo MA. Plasma IL-6, its soluble receptors and F-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand. J. Med. Sci. Sports 2009; [Epub ahead of print].
18. Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med. Hypotheses. 2000; 54: 115-125.
19. Hoffman SW, Moore S, Ellis EF. Isoprostanes: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 1997; 28: 844-849. (Pubitemid 27161473)
20. Yoshiuchi K, Farkas J, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin. Physiol. Funct. Imaging. 2006; 26: 83-86.
21. Ichise M, Salit IE, Abbey SE, Chung DG, Gray B, Kirsh JC, Freedman M. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl. Med. Commun. 1992; 13: 767-772.
22. Schwartz RB, Garada BM, Komaroff AL, Tice HM, Gleit M, Jolesz FA, Holman BL. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR imaging and SPECT. AJR Am. J. Roentgenol. 1994; 162: 935-941.
23. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH,Mikovits JA. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009; [Epub ahead of print].
24. Salvemini D, Doyle TM, Cuzzocrea S. Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochem. Soc. Trans. 2006; 34: 965-970.
25. Jason LA, Najar N, Porter N, Reh C. Evaluating the centers for disease control's empirical chronic fatigue syndrome case definition. J. Disability Policy Studies 2009; 20: 93-100.
26. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004; 61: 450-458.
27. Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: Implications for the mitochondrial dysfunction hypothesis. Biol. Psychiatry 2009; 65: 489-494.
28. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct. Funct. 2008; 213: 93-118.